Join
Live feed
·
INSIDERFilingvia Quantisnow
Blueprint Medicines Corporation logo

CHIEF SCIENTIFIC OFFICER Carter Percy H. sold $340,033 worth of shares (2,659 units at $127.88), decreasing direct ownership by 5% to 54,206 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BPMC (Blueprint Medicines Corporation) and more on Quantisnow.